TY - JOUR
T1 - SREBP-1 dimerization specificity maps to both the helix-loop-helix and leucine zipper domains
T2 - Use of a dominant negative
AU - Rishi, Vikas
AU - Gal, Jozsef
AU - Krylov, Dmitry
AU - Fridriksson, Jakob
AU - Boysen, Maria Sandberg
AU - Mandrup, Susanne
AU - Vinson, Charles
PY - 2004/3/19
Y1 - 2004/3/19
N2 - The mammalian SREBP family contains two genes that code for B-HLH-ZIP proteins that bind sequence-specific DNA to regulate the expression of genes involved in lipid metabolism. We have designed a dominant negative (DN), termed A-SREBP-1, that inhibits the DNA binding of either SREBP protein. A-SREBP-1 consists of the dimerization domain of B-SREBP-1 and a polyglutamic acid sequence that replaces the basic region. A-SREBP-1 heterodimerizes with either B-SREBP-1 or B-SREBP-2, and both heterodimers are more stable than B-SREBP-1 bound to DNA. Circular dichroism thermal denaturation studies show that the B-SREBP-1-A-SREBP-1 heterodimer is -9.8 kcal mol-1 dimer -1 more stable than the B-SREBP-1 homodimer. EMSA assays demonstrate that A-SREBP-1 can inhibit the DNA binding of either B-SREBP-1 or B-SREBP-2 in an equimolar competition but does not inhibit the DNA binding of the three B-HLH-ZIP proteins MAX, USF, or MITF, even at 100 molar eq. Chimeric proteins containing the HLH domain of SREBP-1 and the leucine zipper from either MAX, USF, or MITF indicate that both the HLH and leucine zipper regions of SREBP-1 contribute to its dimerization specificity. Transient co-transfection studies demonstrate that A-SREBP-1 can inhibit the transactivation of SREBP-1 and SREBP-2 but not USF. A-SREBP-1 may be useful in metabolic diseases where SREBP family members are overexpressed.
AB - The mammalian SREBP family contains two genes that code for B-HLH-ZIP proteins that bind sequence-specific DNA to regulate the expression of genes involved in lipid metabolism. We have designed a dominant negative (DN), termed A-SREBP-1, that inhibits the DNA binding of either SREBP protein. A-SREBP-1 consists of the dimerization domain of B-SREBP-1 and a polyglutamic acid sequence that replaces the basic region. A-SREBP-1 heterodimerizes with either B-SREBP-1 or B-SREBP-2, and both heterodimers are more stable than B-SREBP-1 bound to DNA. Circular dichroism thermal denaturation studies show that the B-SREBP-1-A-SREBP-1 heterodimer is -9.8 kcal mol-1 dimer -1 more stable than the B-SREBP-1 homodimer. EMSA assays demonstrate that A-SREBP-1 can inhibit the DNA binding of either B-SREBP-1 or B-SREBP-2 in an equimolar competition but does not inhibit the DNA binding of the three B-HLH-ZIP proteins MAX, USF, or MITF, even at 100 molar eq. Chimeric proteins containing the HLH domain of SREBP-1 and the leucine zipper from either MAX, USF, or MITF indicate that both the HLH and leucine zipper regions of SREBP-1 contribute to its dimerization specificity. Transient co-transfection studies demonstrate that A-SREBP-1 can inhibit the transactivation of SREBP-1 and SREBP-2 but not USF. A-SREBP-1 may be useful in metabolic diseases where SREBP family members are overexpressed.
UR - http://www.scopus.com/inward/record.url?scp=1642523622&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1642523622&partnerID=8YFLogxK
U2 - 10.1074/jbc.M308000200
DO - 10.1074/jbc.M308000200
M3 - Article
C2 - 14702347
AN - SCOPUS:1642523622
SN - 0021-9258
VL - 279
SP - 11863
EP - 11874
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 12
ER -